Oxelumab
Oxelumab is a human monoclonal antibody targeting OX40L designed for the treatment of asthma.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Oxelumab is a human monoclonal antibody targeting OX40L designed for the treatment of asthma. Oxelumab was developed by Genentech and co-developed by Roche.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1324063842 under CC BY-SA 4.0; modifications have been made.